Lisanti Capital Growth LLC Purchases Shares of 54,190 Evolent Health, Inc. (NYSE:EVH)

Lisanti Capital Growth LLC purchased a new position in Evolent Health, Inc. (NYSE:EVH) during the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 54,190 shares of the technology company’s stock, valued at approximately $1,790,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. lifted its position in Evolent Health by 2.7% during the third quarter. Vanguard Group Inc. now owns 10,594,640 shares of the technology company’s stock valued at $288,492,000 after purchasing an additional 274,288 shares during the last quarter. Wellington Management Group LLP lifted its holdings in shares of Evolent Health by 11.9% in the 3rd quarter. Wellington Management Group LLP now owns 4,239,198 shares of the technology company’s stock valued at $115,433,000 after acquiring an additional 449,664 shares during the last quarter. Rock Springs Capital Management LP grew its position in Evolent Health by 1.6% in the third quarter. Rock Springs Capital Management LP now owns 3,865,000 shares of the technology company’s stock worth $105,244,000 after acquiring an additional 61,500 shares in the last quarter. RA Capital Management L.P. bought a new stake in Evolent Health during the third quarter worth approximately $74,520,000. Finally, Bank of New York Mellon Corp raised its position in Evolent Health by 8.7% during the third quarter. Bank of New York Mellon Corp now owns 1,655,609 shares of the technology company’s stock valued at $45,082,000 after purchasing an additional 133,038 shares during the period.

Evolent Health Trading Up 1.4 %

Shares of NYSE:EVH traded up $0.38 during trading on Tuesday, reaching $27.62. 1,398,399 shares of the company were exchanged, compared to its average volume of 943,595. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.01 and a current ratio of 1.01. The business’s fifty day simple moving average is $31.28 and its 200-day simple moving average is $30.28. Evolent Health, Inc. has a 12-month low of $23.33 and a 12-month high of $35.83.

Evolent Health (NYSE:EVH) last issued its earnings results on Thursday, February 22nd. The technology company reported $0.15 earnings per share for the quarter, beating analysts’ consensus estimates of $0.02 by $0.13. Evolent Health had a positive return on equity of 6.60% and a negative net margin of 5.76%. The business had revenue of $556.06 million during the quarter, compared to analyst estimates of $541.87 million. On average, equities analysts anticipate that Evolent Health, Inc. will post 0.87 earnings per share for the current year.

Analyst Upgrades and Downgrades

EVH has been the topic of several analyst reports. JPMorgan Chase & Co. cut their target price on Evolent Health from $53.00 to $52.00 and set an “overweight” rating on the stock in a research report on Friday, March 15th. William Blair reiterated an “outperform” rating on shares of Evolent Health in a research report on Tuesday, January 9th. Citigroup started coverage on shares of Evolent Health in a report on Monday, April 22nd. They issued a “buy” rating and a $40.00 target price for the company. Canaccord Genuity Group cut their price target on shares of Evolent Health from $45.00 to $44.00 and set a “buy” rating on the stock in a report on Thursday, March 28th. Finally, Oppenheimer began coverage on shares of Evolent Health in a research note on Friday, March 1st. They issued an “outperform” rating and a $45.00 price objective for the company. One research analyst has rated the stock with a sell rating, one has issued a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat, Evolent Health currently has an average rating of “Moderate Buy” and a consensus price target of $42.70.

Evolent Health Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.